FDA Inspection
Delpharm Meppel B.V.Delpharm Meppel B.V. – FDA Inspection, Jan 26, 2022
Record Details
This FDA Inspection record concerns Delpharm Meppel B.V., with an inspection on January 26, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Delpharm Meppel B.V.
- Inspection Date
- January 26, 2022
- Product Type
- Drugs
View Company Profile
ID · fab8a7aa-afed-4303-b724-c810a5d7a47b
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1240331
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Delpharm Meppel B.V.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| October 31, 2024 | Not classified | Office of Inspections and Investigations | |
| June 27, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Delpharm Meppel B.V.
- FDA Inspection 1288212 - 2024-10-31
- FDA Inspection 885871 - 2014-06-27
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.